The Justice of Rio Grande do Norte authorized the Reconstruir association to cultivate cannabis for medicinal purposes, benefiting over 700 families and setting a precedent for the therapeutic use of the plant in Brazil

Understand how science organizes cannabis, its subspecies, varieties, and the historical and therapeutic importance of the plant

Study gathers 18 researches and suggests that cannabis compounds may favor healthy aging, with benefits in inflammation, cognition, and quality of life

On Deusa Cast, lawyer Larissa Meneghel details how the five-year deadline set forth in RDC-327 for clinical cannabis research works and comments on the renewal proposal under review by Anvisa

Country advances with historic law and regulations that can transform agriculture, economy, and environment

Pharmacy student at Unifesp reveals, in a study, that cannabis can alleviate symptoms and improve the quality of life of patients with autoimmune diseases

The new law provides for medical training, patient regulation, and guarantee of access to cannabis-derived products in the municipal health system

Deadline set by STJ puts pressure on ministries and Anvisa to conclude pending stages of the action plan

Study by USP and Fiocruz shows that cannabidiol may reverse symptoms associated with autism in an animal model, paving the way for new treatments of ASD

Public hearing will present a balance of the first year of cannabis in the São Paulo public health system and will encourage projects in science, innovation, and social impact

Experts point out that the US experience can accelerate national development

Partnership strengthens the brand and boosts awareness actions on medical cannabis in Germany

According to Clayton Medeiros, access to health should not depend on habeas corpus, but on clear and inclusive public policies

Proposal from the European Commission paves the way for full regulation of hemp and strengthening of the non-psychoactive cannabis market

The President emphasized the responsibility of the appointees and reinforced the importance of the agencies for the country's development

Paula Scanapieco, commercial manager at Mile Express, explains on Deusa Cast how RDC 660 ensures access for Brazilian patients to cannabis medications through international logistics

Paula Scanapieco, commercial manager at Mile Express, explains on Deusa Cast how RDC 660 ensures access for Brazilian patients to cannabis medications through international logistics

Understand how the substance can influence appetite, anxiety, and mood, and what essential medical care is needed

South African researchers identify rare phenolic compounds, flavoalkaloids, in cannabis leaves for the first time, revealing new medicinal potential of the plant

Organizations are pressuring President Trump to legalize marijuana in the US, going beyond mere rescheduling and seeking to repair the damages of historical prohibition

Advancements in automation, artificial intelligence, and blockchain are transforming how producers optimize yields, reduce costs, and ensure quality

Study indicates that medicinal cannabis shows promising results in the treatment of orofacial pain in Dentistry, but further studies on safety and clinical application are still needed

Proposal aims to transform seized cannabis into input for research and medications

Experts point out that federal legalization could open doors for national trademarks, but obstacles still persist

First placebo-controlled study shows that vaporized cannabis, especially the THC/CBD combination, can reduce pain and symptoms of acute migraine in just a few hours

The event brought together students and professionals who see the event as a unique opportunity for exchange, scientific updating, and connection with the future of medicine

Regulatory advances expand access to cannabis treatments for animals, but veterinarians still face barriers in prescribing and regulating products

The study included clinical trials with adults with major depressive disorder (MDD) or treatment-resistant depression (TRD)

Deusa Cast #43 discusses the paths of cannabis: human, pets, and construction industry.

The oncologic pain market is expected to grow from $6.53 billion in 2024 to $11.81 billion by 2034, driven by opioids, non-opioids, and medicinal cannabis as a promising alternative in relieving pain for cancer patients